Search Results - "SEDLACEK, P"

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation by Corbacioglu, S, Carreras, E, Ansari, M, Balduzzi, A, Cesaro, S, Dalle, J-H, Dignan, F, Gibson, B, Guengoer, T, Gruhn, B, Lankester, A, Locatelli, F, Pagliuca, A, Peters, C, Richardson, P G, Schulz, A S, Sedlacek, P, Stein, J, Sykora, K-W, Toporski, J, Trigoso, E, Vetteranta, K, Wachowiak, J, Wallhult, E, Wynn, R, Yaniv, I, Yesilipek, A, Mohty, M, Bader, P

“…The advances in hematopoietic cell transplantation (HCT) over the last decade have led to a transplant-related mortality below 15%. Hepatic sinusoidal…”
Get full text

Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: results from a prospective, multicenter registry by van Gestel, J P J, Bierings, M B, Dauger, S, Dalle, J-H, Pavlíček, P, Sedláček, P, Monteiro, L M, Lankester, A, Bollen, C W

“…Exact data on prognosis of children receiving invasive mechanical ventilation (IMV) after allogeneic hematopoietic SCT (HSCT) is lacking. We therefore started…”
Get full text

Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel by Angelucci, Emanuele, Matthes-Martin, Susanne, Baronciani, Donatella, Bernaudin, Françoise, Bonanomi, Sonia, Cappellini, Maria Domenica, Dalle, Jean-Hugues, Di Bartolomeo, Paolo, de Heredia, Cristina Díaz, Dickerhoff, Roswitha, Giardini, Claudio, Gluckman, Eliane, Hussein, Ayad Achmed, Kamani, Naynesh, Minkov, Milen, Locatelli, Franco, Rocha, Vanderson, Sedlacek, Petr, Smiers, Frans, Thuret, Isabelle, Yaniv, Isaac, Cavazzana, Marina, Peters, Christina

“…Thalassemia major and sickle cell disease are the two most widely disseminated hereditary hemoglobinopathies in the world. The outlook for affected individuals…”
Get full text

Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL by Kotrova, M, van der Velden, V H J, van Dongen, J J M, Formankova, R, Sedlacek, P, Brüggemann, M, Zuna, J, Stary, J, Trka, J, Fronkova, E

“…Minimal residual disease (MRD) monitoring via quantitative PCR (qPCR) detection of Ag receptor gene rearrangements has been the most sensitive method for…”
Get full text

Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group by Balduzzi, A, Dalle, J-H, Jahnukainen, K, von Wolff, M, Lucchini, G, Ifversen, M, Macklon, K T, Poirot, C, Diesch, T, Jarisch, A, Bresters, D, Yaniv, I, Gibson, B, Willasch, A M, Fadini, R, Ferrari, L, Lawitschka, A, Ahler, A, Sänger, N, Corbacioglu, S, Ansari, M, Moffat, R, Dalissier, A, Beohou, E, Sedlacek, P, Lankester, A, De Heredia Rubio, C D, Vettenranta, K, Wachowiak, J, Yesilipek, A, Trigoso, E, Klingebiel, T, Peters, C, Bader, P

“…Fertility preservation is an urgent challenge in the transplant setting. A panel of transplanters and fertility specialists within the Pediatric Diseases…”
Get full text

Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases by Slatter, M A, Boztug, H, Pötschger, U, Sykora, K-W, Lankester, A, Yaniv, I, Sedlacek, P, Glogova, E, Veys, P, Gennery, A R, Peters, C

“…An increasing number of children with non-malignant diseases can be cured by allogeneic haematopoietic stem cell transplantation (HSCT). Treosulfan ( L…”
Get full text

Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT by Król, L, Stuchlý, J, Hubáček, P, Keslová, P, Sedláček, P, Starý, J, Hrušák, O, Kalina, T

“…Depletion of cellular immunity as a consequence of conditioning before allogeneic hematopoietic SCT (HSCT) frequently results in CMV reactivation, which may in…”
Get full text

Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working Party by Diesch-Furlanetto, T, Rovó, A, Galimard, J E, Szinnai, G, Dalissier, A, Sedlacek, P, Bodova, I, Roussou, V K, Gibson, B E, Poiré, X, Fagioli, F, Pichler, H, Faraci, M, Gumy-Pause, F G, Dalle, J H, Balduzzi, A, Bader, P, Corbacioglu, S

“…Abstract STUDY QUESTION What are the characteristics of patients with conceptions transplanted in childhood and adolescence? SUMMARY ANSWER Insemination and…”
Get full text

Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure by BOELENS, J. J, WYNN, R. F, SEDLACEK, P, ROVELLI, A, UITERWAAL, C. S. P. M, WULFFRAAT, N, O'MEARA, A, VEYS, P, BERTRAND, Y, SOUILLET, G, WRAITH, J. E, FISCHER, A, CAVAZZANA-CALVO, M, SYKORA, K. W

“…Hurler's syndrome (HS), the most severe form of mucopolysaccharidosis type-I, causes progressive deterioration of the central nervous system and death in…”
Get full text

Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease by HORVATH, R, ROZKOVA, D, LAST'OVICKA, J, POLOUCKOVA, A, SEDLACEK, P, SEDIVA, A, SPISEK, R

“…Summary Hyper‐immunoglobulin (Ig)E syndrome (HIES) is a primary immunodeficiency associated with mutations in STAT3 resulting in impaired development of T…”
Get full text

Hydrops fetalis and failure of hematopoietic stem cell transplantation – A long route to the diagnosis of SPTA1-associated hereditary spherocytosis by Svaton, M., Sukova, M., Sedlacek, P., Skotnicova, A., Vodickova, E., van Wijk, R., Divoka, M., Mojzikova, R., Kalina, T., Trka, J., Fronkova, E., Stary, J.

Get full text

Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study by Strahm, B, Nöllke, P, Zecca, M, Korthof, E T, Bierings, M, Furlan, I, Sedlacek, P, Chybicka, A, Schmugge, M, Bordon, V, Peters, C, O'Marcaigh, A, de Heredia, C D, Bergstraesser, E, Moerloose, B D, van den Heuvel-Eibrink, M M, Starý, J, Trebo, M, Wojcik, D, Niemeyer, C M, Locatelli, F

“…We report on the outcome of children with advanced primary myelodysplastic syndrome (MDS) transplanted from an HLA-matched sibling (MSD) or an unrelated donor…”
Get full text

Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the Inborn Errors, Infectious Diseases and Pediatric Diseases Working Parties of EBMT by Bontant, T, Sedlaçek, P, Balduzzi, A, Gaspar, B, Cesaro, S, Einsele, H, Peters, C, Dalle, J-H

“…Human CMV infection is a frequent complication after HSC in children with remarkable morbidity and mortality. Antiviral drugs are relatively efficient but have…”
Get full text

State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29–30 September 2015 by Dalle, J-H, Lucchini, G, Balduzzi, A, Ifversen, M, Jahnukainen, K, Macklon, K T, Ahler, A, Jarisch, A, Ansari, M, Beohou, E, Bresters, D, Corbacioglu, S, Dalissier, A, Diaz de Heredia Rubio, C, Diesch, T, Gibson, B, Klingebiel, T, Lankester, A, Lawitschka, A, Moffat, R, Peters, C, Poirot, C, Saenger, N, Sedlacek, P, Trigoso, E, Vettenranta, K, Wachowiak, J, Willasch, A, von Wolff, M, Yaniv, I, Yesilipek, A, Bader, P

“…Nowadays, allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a well-established treatment procedure and often the only cure for many patients…”
Get full text

Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters by Bresters, D, Lawitschka, A, Cugno, C, Pötschger, U, Dalissier, A, Michel, G, Vettenranta, K, Sundin, M, Al-Seraihy, A, Faraci, M, Sedlacek, P, Versluys, A B, Jenkins, A, Lutz, P, Gibson, B, Leiper, A, Diaz, M A, Shaw, P J, Skinner, R, O'Brien, T A, Salooja, N, Bader, P, Peters, C

“…Younger children are considered to be more vulnerable to late effects (LE), which prompted us to study LE in patients after haematopoietic stem cell…”
Get full text

Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood by Keslova, P, Formankova, R, Riha, P, Sramkova, L, Snajderova, M, Malinova, B, Luks, A, Sterba, J, Stary, J, Sedlacek, P

“…Allogeneic hematopoietic stem cell transplantation (HSCT) has become a standard part of therapy for a variety of malignant and non-malignant disorders. With…”
Get more information

Predicting survival using clinical risk scores and non-HLA immunogenetics by Balavarca, Y, Pearce, K, Norden, J, Collin, M, Jackson, G, Holler, E, Dressel, R, Kolb, H-J, Greinix, H, Socie, G, Toubert, A, Rocha, V, Gluckman, E, Hromadnikova, I, Sedlacek, P, Wolff, D, Holtick, U, Dickinson, A, Bickeböller, H

“…Previous studies of non-histocompatibility leukocyte antigen (HLA) gene single-nucleotide polymorphisms (SNPs) on subgroups of patients undergoing allogeneic…”
Get full text

B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL by Fronkova, E, Muzikova, K, Mejstrikova, E, Kovac, M, Formankova, R, Sedlacek, P, Hrusak, O, Stary, J, Trka, J

“…Minimal residual disease (MRD) detection using quantification of clone-specific Ig or TCR rearrangements before and after transplantation in children with…”
Get full text

CMV resistance in patients after allogeneic haematopoietic stem cell transplantation by Hubacek, P, Kouba, M, Boutolleau, D, Pliskova, L, Vejrazkova, E, Keslova, P, Sedlacek, P, Cetkovsky, P

Get full text

Chromosomally integrated HHV-6 in healthy donor and patients treated for haematological malignancy by Hubacek, P, Hrdlickova, A, Muzikova, K, Briksi, A, Zelezna, I, Spacek, M, Zajac, M, Sedlacek, P, Cetkovsky, P, Stary, J

Get full text